EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL - Belgium 

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 11.998.454 81.600 1

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
INSTITUT GUSTAVE ROUSSY5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
UNIVERSITY OF LEEDS5
ABBVIE INC4
BAYER4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON4
INSTITUT CURIE4
ISTITUTO EUROPEO DI ONCOLOGIA4
KATHOLIEKE UNIVERSITEIT LEUVEN4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
OSLO UNIVERSITETSSYKEHUS HF4
REGION HOVEDSTADEN4
STICHTING KATHOLIEKE UNIVERSITEIT4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITA DEGLI STUDI DI TORINO4
UNIVERSITY OF BIRMINGHAM4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA3
ISTITUTO ORTOPEDICO RIZZOLI3
ISTITUTO SUPERIORE DI SANITA3
JANSSEN PHARMACEUTICA NV3
KAROLINSKA INSTITUTE3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
PFIZER LIMITED3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
TTOPSTART BV3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM FREIBURG3
UNIVERSITEIT MAASTRICHT3
WEIZMANN INSTITUTE OF SCIENCE3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
AMGEN2
ARTTIC INNOVATION2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASSOCIATION EISBM2
BAYER PHARMA2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
CENTRE ANTICANCEREUX LEON BERARD2
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD2
CENTRE DE REGULACIO GENOMICA2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
DANISH CANCER SOCIETY2
DEUTSCHE FORSCHUNGSGEMEINSCHAFT2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
EATRIS ERIC2
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL2
EUROPEAN CANCER ORGANISATION2
EUROPEAN CANCER PATIENT COALITION2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
HELMHOLTZZENTRUM DRESDENROSSENDORF EV2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INFRAFRONTIER2
INSTITUT JULES BORDET2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI2
KING'S COLLEGE LONDON2
LUND UNIVERSITY2
MASARYKOVA UNIVERZITA2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
OSPEDALE PEDIATRICO BAMBINO GESU2
OWKIN FRANCE2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
SANOFIAVENTIS2
SARCOMA PATIENTS EURONET EV2
SERVICIO MADRILENO DE SALUD2
ST ANNA KINDERKREBSFORSCHUNG2
STICHTING EUROPEAN UROLOGICAL FOUNDATION2
STICHTING VUMC2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
UNIVERSIDAD POLITECNICA DE MADRID2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAET BERN2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF TAMPERE2
UNIVERSITY OF YORK2
UPPSALA UNIVERSITET2
WARSZAWSKI UNIWERSYTET MEDYCZNY2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
AARHUS UNIVERSITETSHOSPITAL1
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ABBVIE DEUTSCHLAND GMBH & CO KG1
ABO AKADEMI1

Constancy:

Total number of partners: 592
Partner loyalty:
Frequent Partner: (> 2 projects): 131
Rare Partner: 461
Frequent / Rare Partner Ratio: 0.28

Project overview:

Start dateProjectacronymrolefundingpartners
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428